3M Company (Minnesota Mining and Manufacturing Company) - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended June 30, 1999. 3M is a diversified technology company. During the second quarter of 1999, the company reorganized its management reporting structure, separating the Industrial and Consumer businesses into two distinct markets: Industrial and Electro; and Consumer and Office. The company also completed the divestiture of Eastern Heights Bank and its Cardiovascular Systems business on June 30, 1999.
Key Financial Metrics
| Metric (in millions) | Q2 1999 | Q2 1998 | YTD 6mo 1999 | YTD 6mo 1998 |
|---|---|---|---|---|
| Net Sales | $3,863 | $3,770 | $7,639 | $7,470 |
| Operating Income | $804 | $641 | $1,453 | $1,321 |
| Net Income | $476 | $386 | $860 | $786 |
| Diluted EPS | $1.17 | $0.94 | $2.12 | $1.92 |
| Operating Margin | 20.8% | 17.0% | 19.0% | 17.7% |
| Cash from Operations (YTD) | $1,713 | $767 | ||
| Total Debt | ||||
| Working Capital | $2,558 | $1,932 | ||
| Current Ratio |
Note: Total debt decreased to $2.301 billion as of June 30, 1999. Working capital increased to $2.558 billion.
Material Changes vs. Prior Period
- Revenue Growth: Worldwide sales increased 2.5% in Q2 and 2.3% year-to-date. Growth was driven by volume increases (approx. 3.5% in Q2) and slight price increases, partially offset by negative currency translation effects (-1.5% in Q2).
- Profitability: Operating income rose 25.4% in Q2 and 10.0% year-to-date. Gross margins improved due to lower raw material costs and restructuring actions. Cost of goods sold decreased to 56.6% of sales in Q2 (down 0.8 percentage points from prior year).
- One-Time Gains: Q2 results included a pre-tax gain of $104 million ($55 million after tax) from the divestiture of Eastern Heights Bank and Cardiovascular Systems assets. Excluding these items, operating income was $700 million.
- Cash Flow: Net cash provided by operating activities surged to $1.713 billion year-to-date, compared to $767 million in the prior year. This was aided by a $450 million decline in inventories and a $57 million net cash inflow from mammary implant litigation (compared to a $185 million outflow in the prior year).
- Debt Reduction: Total debt decreased by $805 million from year-end 1998, reducing the debt-to-total capital ratio to 27%.
Guidance, Outlook, and Risks
- Restructuring: The company expects to complete a restructuring plan by year-end 1999, reducing approximately 4,500 positions. This is expected to yield annual pre-tax savings of about $250 million. Implementation costs for 1999 are estimated at $35 million.
- Sales Outlook (H2 1999): International sales in local currencies are expected to grow 7-8%. Asia Pacific is projected to see double-digit growth, Europe 4-5%, and Latin America double-digit growth. U.S. sales are expected to grow 3-4%.
- Capital Spending: Expected to total $1.1 billion for 1999, down from $1.43 billion in 1998.
- Year 2000 Readiness: The company has spent approximately $60 million of an estimated $76 million total cost. As of June 30, 1999, 98% of core U.S. IT systems and 99% of non-U.S. IT systems deemed "Vital" or "Critical" are compliant. Risks remain regarding third-party suppliers and infrastructure.
- Legal Proceedings (Breast Implants): The company faces 4,631 lawsuits. It has accrued $37 million in liabilities after paying $1.063 billion to date. It has accrued $610 million in receivables for insurance recoveries, substantially all of which are contested. The company believes its insurance coverage is sufficient but litigation outcomes remain uncertain.
- European Monetary Union (Euro): The company anticipates spending $35-50 million to convert European IT systems to the euro by December 31, 2001. The euro is expected to increase price competition but also offer efficiencies.
Investor Verification Checklist
- Divestiture Impact: Verify the sustainability of operating income growth excluding the $104 million one-time gain from divestitures.
- Implant Litigation: Monitor the status of the $610 million contested insurance receivable and the outcome of the Minnesota/Texas insurance coverage litigation.
- Year 2000 Costs: Track actual costs against the $76 million estimate and monitor for any unanticipated disruptions from third-party suppliers.
- Restructuring Savings: Confirm the realization of the projected $250 million in annual pre-tax savings by the end of 1999.
- Currency Exposure: Assess the impact of the strong U.S. dollar on future earnings, as currency translation reduced sales by 1.5% in Q2.